Riga East Clinical University Hospital, Laboratory "Latvian Centre of Infectious Diseases", National Microbiology Reference Laboratory, Riga, Latvia; Riga Stradins University, Department of Infectology, Latvia.
Riga East Clinical University Hospital, Laboratory "Latvian Centre of Infectious Diseases", National Microbiology Reference Laboratory, Riga, Latvia.
J Infect Public Health. 2023 Sep;16(9):1462-1470. doi: 10.1016/j.jiph.2023.07.012. Epub 2023 Jul 29.
In Latvia outbreaks of the HAV were observed between 2008 and early 2010 and again in 2017-2018. However, the risks of introducing and spreading infection still exist, as the virus spreads easily when personal hygiene is not followed.
To determine the spread of HAV subgenotypes in the territory of Latvia the VP1/P2A genomic region of HAV was amplified and sequenced for 259 case serum samples. The study carried out a molecular biological investigation and molecular epidemiological investigation. Demographic data (sex, age), disease data (hepatitis symptoms, hospitalization, vaccination) and epidemiology data (part of the outbreak, possible source of infection, recent travel) were collected. Based on the obtained sequences, the phylogenetic tree was built and analyzed for the homology and belonging to different isolated HAV clusters from other countries.
From the obtained data, it was concluded that HAV subgenotype IA had 13 clusters and 12 sporadic cases, HAV subgenotype IB had eight clusters and 11 sporadic cases, HAV subgenotype IIIA had one cluster and nine sporadic cases. It was found that the sources of infection among the investigated cases were different, they were mostly associated with contact with a patient with HAV, travel, as well as between persons who inject drugs and men who have sex with men, and the prevalence of HAV similar sequences was observed in different years. It was concluded that patients with HAV subgenotype IA had the longest hospitalization duration and averaged 9.3 days, while patients with subgenotype IB - 7.3 days, subgenotype IIIA - 7.7 days. Analyzing the data on vaccination, it was found that mostly all were not vaccinated or had an unknown vaccination status.
All of this has led to the conclusion that the application of molecular biological methods of the HAV and a careful analysis of epidemiological data can help to better understand the ways of spreading the infection, investigate local outbreaks, detect cases of imported infection and track the recirculation of the virus.
在拉脱维亚,2008 年至 2010 年初以及 2017-2018 年期间均观察到甲型肝炎病毒(HAV)的爆发。然而,由于个人卫生不到位时病毒极易传播,因此仍然存在病毒输入和传播的风险。
为了确定 HAV 亚型在拉脱维亚境内的传播情况,对 259 例血清样本的 HAV VP1/P2A 基因组区进行了扩增和测序。该研究进行了分子生物学调查和分子流行病学调查。收集了人口统计学数据(性别、年龄)、疾病数据(肝炎症状、住院、疫苗接种)和流行病学数据(部分暴发、可能的感染源、近期旅行)。根据获得的序列,构建了系统进化树,并对同源性进行了分析,以确定不同国家分离的 HAV 聚类。
从获得的数据中得出结论,HAV 亚基因型 IA 有 13 个聚类和 12 个散发病例,HAV 亚基因型 IB 有 8 个聚类和 11 个散发病例,HAV 亚基因型 IIIA 有 1 个聚类和 9 个散发病例。研究发现,调查病例的感染源不同,主要与甲型肝炎患者接触、旅行以及与静脉吸毒者和男男性行为者有关,并且在不同年份都观察到了 HAV 相似序列的流行。结论为,IA 亚基因型 HAV 患者的住院时间最长,平均为 9.3 天,而 IB 亚基因型患者的住院时间为 7.3 天,IIIA 亚基因型患者的住院时间为 7.7 天。分析疫苗接种数据发现,大多数患者均未接种疫苗或疫苗接种情况未知。
综上所述,应用 HAV 的分子生物学方法并仔细分析流行病学数据,可以帮助更好地了解感染传播方式,调查本地暴发,发现输入性感染病例,并跟踪病毒的循环。